Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.

Catherina X Pan William C Lau Daniel Y Kim Charles B Lau Rachael Rowley Ruhi Kanwar Nicole R LeBoeuf Vinod E Nambudiri

J Am Acad Dermatol

Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Dana-Farber Cancer Institute, Center for Cutaneous Oncology, Boston, Massachusetts. Electronic address:

Published: December 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2023.07.1029	DOI Listing

Publication Analysis

Top Keywords

association baseline

baseline lactate

lactate dehydrogenase

dehydrogenase immune-related

immune-related adverse

adverse events

events patients

patients melanoma

melanoma varies

varies tumor

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!